The CDK1 inhibitor RO3306 improves the response of BRCA-proficient breast cancer cells to PARP inhibition
Qing Xia(Anhui Medical University), Wenqi Jiang(Shandong Tumor Hospital)
Cited by 58
Related Papers
A global benchmark of algorithms for segmenting the left atrium from late gadolinium-enhanced cardiac magnetic resonance imaging
|Medical Image Analysis|2020|475